Lombard Medical Inc (EVAR) Announces Earnings Results, Beats Expectations By $0.28 EPS

Lombard Medical Inc (NASDAQ:EVAR) announced its quarterly earnings results on Monday. The medical equipment provider reported $0.00 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.28) by $0.28. Lombard Medical had a negative net margin of 274.92% and a negative return on equity of 115.39%.

Shares of Lombard Medical (NASDAQ:EVAR) traded down 3.3006% during trading on Friday, hitting $0.5801. 51,765 shares of the stock traded hands. The company’s market cap is $11.54 million. Lombard Medical has a 52 week low of $0.50 and a 52 week high of $1.94. The firm’s 50-day moving average price is $0.68 and its 200-day moving average price is $0.71.

Earnings History for Lombard Medical (NASDAQ:EVAR)

TRADEMARK VIOLATION WARNING: “Lombard Medical Inc (EVAR) Announces Earnings Results, Beats Expectations By $0.28 EPS” was first posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this piece on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece can be read at https://www.chaffeybreeze.com/2017/04/21/lombard-medical-inc-evar-set-to-announce-quarterly-earnings-on-monday-updated.html.

About Lombard Medical

Lombard Medical, Inc is a medical technology company. The Company specializes in developing, manufacturing, and marketing endovascular stent-grafts that address medical needs in the repair of aortic aneurysms. The Company’s Aorfix is an abdominal aortic aneurysm (AAA) stent-graft for the treatment of AAAs with angulation at the neck of the aneurysm of over 90 degrees.

5 Day Chart for NASDAQ:EVAR

Receive News & Ratings for Lombard Medical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lombard Medical Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply